Robert E. Waltermire - 12 Dec 2023 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Role: Senior VP, Chief Pharma Dev.
Signature: /s/ Brian J. Lynch*
Issuer symbol: MDGL
Transactions as of: 12 Dec 2023
Net transactions value: -$512,604
Form type: 4
Filing time: 14 Dec 2023, 16:30:08 UTC
Previous filing: 02 Mar 2023
Next filing: 18 Dec 2023
SEC: View on sec.gov

Quoteable Key Fact

"Robert E. Waltermire filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 14 Dec 2023."

Quick Takeaways

This page summarizes Robert E. Waltermire's Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
8 reported transactions and 2 derivative rows are listed below.
Filing timestamp: 14 Dec 2023, 16:30.

What Changed

Previous filing in this sequence was filed on 02 Mar 2023.
Current net transaction value: -$512,604.

Why This Matters

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDGL	Common Stock	Options Exercise	$114,296	+1,300	+23%	$87.92	6,967	12 Dec 2023	Direct	F1
transaction	MDGL	Common Stock	Sale	$108,000	-500	-7.2%	$216.00	6,467	12 Dec 2023	Direct
transaction	MDGL	Common Stock	Sale	$175,200	-800	-12%	$219.00	5,667	12 Dec 2023	Direct
transaction	MDGL	Common Stock	Options Exercise	$219,800	+2,500	+44%	$87.92	8,167	13 Dec 2023	Direct	F1
transaction	MDGL	Common Stock	Sale	$337,500	-1,500	-18%	$225.00	6,667	13 Dec 2023	Direct
transaction	MDGL	Common Stock	Sale	$226,000	-1,000	-15%	$226.00	5,667	13 Dec 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDGL	Stock Option (Right to Buy)	Options Exercise	$0	-1,300	-5.2%	$0.000000	23,700	12 Dec 2023	Common Stock	1,300	$87.92	Direct	F1
transaction	MDGL	Stock Option (Right to Buy)	Options Exercise	$0	-2,500	-11%	$0.000000	21,200	13 Dec 2023	Common Stock	2,500	$87.92	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	All shares issued pursuant to the exercise of the options reported herein represent 3,800 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

Content

All shares issued pursuant to the exercise of the options reported herein represent 3,800 shares underlying an overall option award of 35,000 shares. All exercised options had vested. As to the overall option for 35,000 shares, 25% of the shares underlying the option vested on August 2, 2022 and, thereafter, 6.25% of the shares vested, or will vest, on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.

Remarks:

*As attorney-in-fact for Reporting Person